Latest News

Vaginal estrogen not recommended with aromatase inhibitors

Publish date: October 24, 2022

 

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

FDA warns of cancer risk in scar tissue around breast implants
MDedge Internal Medicine
Time to cancer diagnoses in U.S. averages 5 months
MDedge Internal Medicine
A farewell to arms? Drug approvals based on single-arm trials can be flawed
MDedge Internal Medicine
High BMI linked to better survival for cancer patients treated with ICI, but for men only
MDedge Internal Medicine
Genetic tests create treatment opportunities and confusion for breast cancer patients
MDedge Internal Medicine
Cost paramount when choosing metastatic breast cancer treatment
MDedge Internal Medicine
Cancer as a full contact sport
MDedge Internal Medicine
Is early-onset cancer an emerging global epidemic?
MDedge Internal Medicine
What is known about sexual dysfunction after breast cancer?
MDedge Internal Medicine
Hair straighteners’ risk too small for docs to advise against their use
MDedge Internal Medicine